Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma Phase 2 ClinicalTrials
Lung Neoplasms Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Aneurysm, Dissecting; Neoplasms Phase 2 ClinicalTrials
Lung Neoplasms Phase 3 ClinicalTrials
CONTENTS